Novo Nordisk extends rebound on Eli Lilly trial results: are investors reversing positions?

Novo Nordisk shares rose over 5% in morning trade on Friday, ranking among the top gainers on the STOXX index, after investors reacted to trial results from Eli Lilly’s oral…